Mingels, Clemens http://orcid.org/0000-0001-6761-5323
Weissenrieder, Luis
Zeimpekis, Konstantinos
Sari, Hasan
Nardo, Lorenzo
Caobelli, Federico
Alberts, Ian
Rominger, Axel
Pyka, Thomas
Funding for this research was provided by:
University of Bern
Article History
Received: 19 December 2023
Accepted: 5 February 2024
First Online: 22 February 2024
Declarations
:
: The cantonal ethics committee approved this patient acquisition (KEK-Nr.: 2022–00486). The study was performed in accordance with the declaration of Helsinki.
: HS is a full-time employee of Siemens Healthcare AG, Switzerland. AR has received research support and speaker honoraria from Siemens. LN is PI of service agreement with United Imaging Healthcare. LN is site PI of clinical trials supported by Novartis Pharmaceuticals Corporation. LN is PI of a clinical trail supported by Telix Pharmaceuticals. LN is PI of a clinical trial supported by Lantheus Medical Imaging. LN is PI of a clinical trail supported by GE Healthcare. LN is Co-PI of a clinical trial supported by Lilly. LN has a speaker engagement agreement with Lilly UCC Davis has a share revenue agreement with United Imaging Healthcare. All other authors have no conflicts of interest to report.